RxDoctor Payments Data

Sofia Miranda

Pediatrics · Miami, FLNPI 1093003220

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Sanofi accounts for 60.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2024 at $25,570 and has fallen 50.9% since, to $12,564 in 2025. Among pediatrics clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$66,546in general payments, 2019–2025

Across 189 payments — averaging $352.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$40K
  • Genentech USA, Inc.$12K
  • Novo Nordisk$5K
  • Pfizer$5K
  • Octapharma USA, Inc.$3K
  • Merz Pharmaceuticals, LLC$490
  • plus $1K from 16 others

What the payments were for

  • Consulting fees$13,74121%
  • Speaking & faculty fees$32,65349%
  • Travel & lodging$15,43123%
  • Food & beverage$4,7217%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$66,546 in reported general payments places this provider in the 95th percentile of 3,964 pediatrics providers in Florida.

See all pediatrics providers in Florida →

Other pediatrics in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →